Feb 5, 2026

Featuring an interview with Dr Terence Friedlander, including the following topics:

• Final analysis of the Phase III, open-label, randomized POTOMAC trial (0:00)
• KEYNOTE-905 trial: Perioperative enfortumab vedotin with pembrolizumab for muscle-invasive bladder cancer (MIBC) (5:25)
• The neoadjuvant gemcitabine...

Jul 23, 2025

Featuring perspectives from Prof Laurence Albiges and Dr Tian Zhang, including the following topics:

• Introduction: Adjuvant Immunotherapy for Localized Renal Cell Carcinoma (RCC) (0:00)
• Metastatic Clear Cell RCC — Faculty Presentation (9:22)
• Metastatic Clear Cell RCC — Survey Questions (20:24)
• Non-Clear Cell RCC...

Jul 10, 2025

Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Prof Thomas Powles, moderated by Dr Galsky, including the following topics:

• Introduction (0:00)
• Current and Future Management of Muscle-Invasive Bladder Cancer — Prof Powles (1:14)
• Novel Intravesical Therapies Under Evaluation for...

May 22, 2025

Featuring perspectives from Dr Shilpa Gupta and Dr Jonathan E Rosenberg, including the following topics:

• Management of Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Gupta (0:00)
• Optimizing the Treatment of Metastatic UBC — Dr Rosenberg (21:52)

CME information and select...

Apr 23, 2025

Featuring an interview with Dr William K Oh, including the following topics:

• Use of secondary hormonal agents for patients with metastatic hormone-sensitive prostate cancer (0:00)
• Data supporting the clinical activity of PARP inhibitors for metastatic castration-resistant prostate cancer...